cyclopentane has been researched along with urethane in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haga, M; Kubota, Y; Matsumoto, T; Miura, K; Sasaki, K; Wada, K; Yagi, M | 1 |
| BATES, L; KULKA, P; SAFIER, S; SATTERWHITE, H; SOLNEY, E; TARNOWSKI, G | 1 |
| Agniswamy, J; Amano, M; Chapsal, BD; Ghosh, AK; Mitsuya, H; Steffey, M; Wang, YF; Weber, IT | 1 |
| Fan, S; Jiang, Z; Liao, Y; Liu, C; Tang, H; Wang, J; Xiong, J; Zhou, B; Zhou, S; Zou, M | 1 |
4 other study(ies) available for cyclopentane and urethane
| Article | Year |
|---|---|
Isolation of bilobalide and ginkgolide A from Ginkgo biloba L. shorten the sleeping time induced in mice by anesthetics.
Topics: Anesthetics; Animals; Chloralose; Cyclopentanes; Diterpenes; Furans; Ginkgolides; Hexobarbital; Lactones; Male; Mice; Mice, Inbred Strains; Plant Extracts; Plants, Medicinal; Sleep; Time Factors; Urethane | 1993 |
EFFECTS OF CHEMICAL TREATMENT IN VITRO OF NELSON MOUSE ASCITES TUMOR CELLS ON THEIR TRANSPLANTABILITY AND ON SOME INDICES OF GLUCOSE METABOLISM.
Topics: Animals; Antineoplastic Agents; Ascites; Aziridines; Carbohydrate Metabolism; Carbon Isotopes; Carboxylic Acids; Carcinoma, Ehrlich Tumor; Cyclopentanes; Dactinomycin; Glucose; In Vitro Techniques; Mechlorethamine; Methotrexate; Mice; Mitomycin; Mitomycins; Neoplasms, Experimental; Research; Urethane | 1963 |
Substituent effects on P2-cyclopentyltetrahydrofuranyl urethanes: design, synthesis, and X-ray studies of potent HIV-1 protease inhibitors.
Topics: Binding Sites; Crystallography, X-Ray; Cyclopentanes; Darunavir; Drug Design; Drug Resistance, Viral; Furans; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Leukocytes, Mononuclear; Models, Molecular; Stereoisomerism; Structure-Activity Relationship; Sulfonamides; Urethane | 2012 |
G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
Topics: Adenocarcinoma; Aged; Animals; Apoptosis; Blotting, Western; Carcinogens; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Movement; Cell Proliferation; Cyclopentanes; Disease Progression; Estradiol; Estrogen Receptor Antagonists; Female; Fulvestrant; Humans; Immunoenzyme Techniques; Lung Neoplasms; Lymphatic Metastasis; Male; Mice; Middle Aged; Neoplasm Staging; Phosphorylation; Prognosis; Quinolines; Receptors, Estrogen; Receptors, G-Protein-Coupled; RNA, Small Interfering; Tissue Array Analysis; Tumor Cells, Cultured; Urethane; Xenograft Model Antitumor Assays | 2015 |